Biora Therapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
Athyrium Group has updated its beneficial ownership in Biora Therapeutics, Inc., reporting an aggregate 49.9% stake, concurrent with the resignation of Jeffrey A. Ferrell from the company's board of directors.